Literature DB >> 3312933

Boiled coffee increases serum low density lipoprotein concentration.

A Aro1, J Tuomilehto, E Kostiainen, U Uusitalo, P Pietinen.   

Abstract

The effects of boiled coffee, filtered coffee, and tea on serum lipoprotein lipids and apoproteins were compared in 42 middle-aged hypercholesterolemic subjects (21 men and 21 women). The subjects consumed the beverages, eight cups a day, in random order during successive 4-week periods with 2-week run-in intervals in a crossover design. The diet was kept unchanged. Statistically significant differences were found between the periods in serum total cholesterol (P less than .0001 ANOVA), LDL cholesterol (P less than .01), and apoprotein B (P less than .01) levels. All differences were due to significantly higher levels during boiled coffee as compared with filtered coffee and tea. No statistically significant differences were found between the filtered coffee and tea periods. There were no differences in serum VLDL cholesterol or triglyceride, HDL cholesterol, and apoprotein A-I concentrations between the periods. Consumption of boiled coffee thus increased the concentration of low density lipoprotein in the serum without affecting its lipid-protein composition. The effect seemed to be determined by the method of brewing.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3312933     DOI: 10.1016/0026-0495(87)90021-7

Source DB:  PubMed          Journal:  Metabolism        ISSN: 0026-0495            Impact factor:   8.694


  11 in total

1.  Coffee, cholesterol, and coronary heart disease.

Authors:  D S Thelle
Journal:  BMJ       Date:  1991-04-06

2.  Boiled coffee does not increase serum cholesterol in gerbils and hamsters.

Authors:  R P Mensink; P L Zock; M B Katan; A C Beynen
Journal:  Z Ernahrungswiss       Date:  1992-03

3.  Coffee and cholesterol: is it all in the brewing? The Tromsø Study.

Authors:  K Bønaa; E Arnesen; D S Thelle; O H Førde
Journal:  BMJ       Date:  1988-10-29

4.  Effects of coffee on serum cholesterol and lipoproteins: the Italian brewing method. Italian Group for the Study of Atherosclerosis and Dismetabolic Diseases, Rome II Center.

Authors:  V Sanguigni; M Gallu; M P Ruffini; A Strano
Journal:  Eur J Epidemiol       Date:  1995-02       Impact factor: 8.082

5.  Coffee consumption after myocardial infarction and risk of cardiovascular mortality: a prospective analysis in the Alpha Omega Cohort.

Authors:  Laura H van Dongen; Famke Jm Mölenberg; Sabita S Soedamah-Muthu; Daan Kromhout; Johanna M Geleijnse
Journal:  Am J Clin Nutr       Date:  2017-08-23       Impact factor: 7.045

6.  Comparison of effect of cafetière and filtered coffee on serum concentrations of liver aminotransferases and lipids: six month randomised controlled trial.

Authors:  R Urgert; S Meyboom; M Kuilman; H Rexwinkel; M N Vissers; M Klerk; M B Katan
Journal:  BMJ       Date:  1996-11-30

Review 7.  The effect of green coffee extract supplementation on cardio metabolic risk factors: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Mehrnaz Morvaridi; Elham Rayyani; Malihe Jaafari; Alireza Khiabani; Mehran Rahimlou
Journal:  J Diabetes Metab Disord       Date:  2020-05-15

Review 8.  The cholesterol-raising factor from coffee beans.

Authors:  R Urgert; M B Katan
Journal:  J R Soc Med       Date:  1996-11       Impact factor: 18.000

Review 9.  Dietary Strategies and Novel Pharmaceutical Approaches Targeting Serum ApoA-I Metabolism: A Systematic Overview.

Authors:  Lotte Smolders; Jogchum Plat; Ronald P Mensink
Journal:  J Nutr Metab       Date:  2017-06-12

10.  Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances.

Authors:  Aurélie Delacrétaz; Frederik Vandenberghe; Anaïs Glatard; Axel Levier; Céline Dubath; Nicolas Ansermot; Séverine Crettol; Mehdi Gholam-Rezaee; Idris Guessous; Murielle Bochud; Armin von Gunten; Philippe Conus; Chin B Eap
Journal:  Front Psychiatry       Date:  2018-11-09       Impact factor: 4.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.